- Home
- FNWD vs NKTX Comparison
FNWD vs NKTX Comparison
Compare FNWD & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWD
- NKTX
- Stock Information
- Founded
- FNWD 1994
- NKTX 2015
- Country
- FNWD United States
- NKTX United States
- Employees
- FNWD N/A
- NKTX N/A
- Industry
- FNWD Savings Institutions
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- FNWD Finance
- NKTX Health Care
- Exchange
- FNWD Nasdaq
- NKTX Nasdaq
- Market Cap
- FNWD 143.6M
- NKTX 147.7M
- IPO Year
- FNWD N/A
- NKTX 2020
- Fundamental
- Price
- FNWD $38.23
- NKTX $1.83
- Analyst Decision
- FNWD Buy
- NKTX Strong Buy
- Analyst Count
- FNWD 1
- NKTX 5
- Target Price
- FNWD $34.00
- NKTX $13.25
- AVG Volume (30 Days)
- FNWD 31.2K
- NKTX 702.8K
- Earning Date
- FNWD 10-28-2025
- NKTX 11-10-2025
- Dividend Yield
- FNWD 1.26%
- NKTX N/A
- EPS Growth
- FNWD N/A
- NKTX N/A
- EPS
- FNWD 1.91
- NKTX N/A
- Revenue
- FNWD $66,563,999.00
- NKTX N/A
- Revenue This Year
- FNWD N/A
- NKTX N/A
- Revenue Next Year
- FNWD $8.42
- NKTX N/A
- P/E Ratio
- FNWD $19.89
- NKTX N/A
- Revenue Growth
- FNWD N/A
- NKTX N/A
- 52 Week Low
- FNWD $26.12
- NKTX $1.31
- 52 Week High
- FNWD $38.49
- NKTX $3.16
- Technical
- Relative Strength Index (RSI)
- FNWD 74.68
- NKTX 40.43
- Support Level
- FNWD $35.00
- NKTX $1.77
- Resistance Level
- FNWD $36.41
- NKTX $1.83
- Average True Range (ATR)
- FNWD 1.28
- NKTX 0.09
- MACD
- FNWD 0.20
- NKTX -0.00
- Stochastic Oscillator
- FNWD 86.32
- NKTX 37.14
About FNWD Finward Bancorp
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.